Showing results (301-310 of 335) with videos related to
Sort By:
Pageof 34
The Journal of Investigative Dermatology|July 10, 2001
Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotidesH Hegyesi, B Somlai, V L Varga, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activitiesMarta Zarandi, Jozsef L Varga, Andrew V Schally, et al.Allergy|August 8, 2015
F12-46C/T polymorphism as modifier of the clinical phenotype of hereditary angioedemaM Speletas, Á Szilágyi, D Csuka, et al.Journal of Pharmaceutical and Biomedical Analysis|June 15, 2004
Identification and quantitation of extractables from cellulose acetate butyrate (CAB) and estimation of their in vivo exposure levelsDecheng Ma, Walter R Wasylaschuk, Christopher Beasley, et al.Allergy|August 10, 2016
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiencyH Farkas, I Martinez-Saguer, K Bork, et al.Proceedings of the National Academy of Sciences of the United States of America|July 20, 2005
Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneGunhild Keller, Andrew V Schally, Kate Groot, et al.Journal of Medicinal Chemistry|April 1, 1987
Thienothiopyran-2-sulfonamides: a novel class of water-soluble carbonic anhydrase inhibitorsG S Ponticello, M B Freedman, C N Habecker, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 20, 2011
Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancerA Papadia, A V Schally, G Halmos, et al.International Journal of Oncology|June 26, 2008
Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colonFlorian Hohla, Angelika Moder, Ursula Mayrhauser, et al.International Journal of Oncology|May 5, 2005
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analogBeatriz Collado, María J Carmena, Manuel Sánchez-Chapado, et al.Pageof 34